Clinical Trials Directory

Trials / Completed

CompletedNCT00974402

Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings

Psychotherapy Treatment of Deployment-related PTSD in Primary Care Settings

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
The University of Texas Health Science Center at San Antonio · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate Cognitive-behavioral therapy (CBT) for deployment-related post-traumatic stress disorder (PTSD) that can be used by behavioral health consultants working with Service Members in the primary care clinic. CBT is a well-researched, very effective individual (one-to-one) treatment that is designed to help people to directly deal with traumatic events they have suffered in the past, including combat. Many Service Members prefer to see behavioral health providers in primary care rather than the mental health clinic. The researchers hope to learn if a brief treatment for PTSD in primary care can be just as useful as more traditional treatment given in the mental health clinic. This study will enroll approximately 45 participants overall; with approximately 30 participants at Wilford Hall Medical Center or Brooke Army Medical Center, and 15 participants to be enrolled at the South Texas Veterans Health Care System over a period of one year.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavioral TherapyThe study investigators have developed a 4-session PTSD treatment plan including a behavioral health consultants (BHC) manual and a patient guide for use in primary care. Therapists will be psychologists who are functioning as behavioral health consultants (BHC) in an integrated primary care clinic. The study will adapt intervention methods for use in the time-constrained primary care environment from Cognitive Behavioral Therapy(ies) that have proven effective for PTSD in specialty mental health care settings. Study participants will receive four 30-minute treatment sessions over six weeks.

Timeline

Start date
2008-03-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2009-09-10
Last updated
2014-09-18

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00974402. Inclusion in this directory is not an endorsement.